Monday, April 17, 2017 11:33:49 AM
) prove of no dilution as in the last two quarters;
2) News of Revenue/deal forecast by Countries interested in our Psoriasis cream;
3) Efficacy results and scientific details with data for our Psoriasis Cream: BREAKTHROUGH IN MEDICINE; (maybe separate PR;
4) Extended study on other skin disease that could be cured with this same Cream: possible skin cancer;
5) Multiple Myeloma update on last year promising preclinical test
6) Sublingual Table current status: possible application for Migraine and PTSD disease and product launch plan;
FEATURED Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM